Supplementary Methods S1 from Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial—Efficacy and Biomarker Discovery
Author/s
author: Laura J. van't Veer, Lajos Pusztai, Hope Rugo, Douglas Yee, Angela DeMichele, Sarah L Blair, Scott Berry, Nola M Hylton, Julie Lang, Amy Jo Chien, Rita Nanda, Tufia C Haddad, Debu Tripathy, Claudine Isaacs, Gillian L Hirst, Anthony D Elias, Gregor Krings, David M Euhus, William Symmans, Laura Esserman, Judy Boughey, Michelle E Melisko, Jane Perlmutter, Don Berry
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.